BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 11, 2013
View Archived Issues
Derma Sciences begins enrollment in phase III DSC-127 trial
Read More
CX3CR1 gene polymorphisms investigated in multiple sclerosis
Read More
DNA-binding protein SATB1 associated with aggressive prostate cancer
Read More
Merck & Co. prepares new BTK inhibitors
Read More
Abbott Laboratories presents novel CCR2 receptor antagonists
Read More
Spanish researchers disclose new DP2 receptor antagonists
Read More
MorphoSys divulges new bispecific monoclonal antibodies
Read More
Nihon University discloses novel apoptosis inducers
Read More
Novel DPP IV inhibitors synthesized at Boehringer Ingelheim
Read More
AstraZeneca patents new MCH1 receptor antagonists
Read More
Scientists at Janssen Pharmaceuticals present new gamma-secretase modulators
Read More
Avanir Pharmaceuticals reports interim data for AVP-786
Read More
Intellect Neurosciences begins preclinical proof-of-concept studies for TauC3
Read More
Bevacizumab improves survival in patients with cervical cancer
Read More
TGFR-1 inhibitor prevents metastasis in animal models of breast cancer
Read More
Gilead Sciences completes acquisition
Read More
Shire begins phase III study in epidermolysis bullosa
Read More
FDA issues draft guidance on developing drugs for early Alzheimer's disease
Read More
Data from phase II Reolysin trial in lung cancer reported
Read More
Glucokinase plus insulin genetic therapy cures diabetes in dogs
Read More
Phospho-p90RSK6 as a predictive marker in ER-positive breast cancer
Read More
EMA committee begins safety review of Diane-35 and generics
Read More
Bayer HealthCare to coordinate newly founded pan-European consortium
Read More
FDA approves second drug for multiple myeloma
Read More
RNL Bio seeks Korean clearance for phase II/III trials of stem cell product
Read More
Novo Nordisk receives complete response letter for Tresiba and Ryzodeg
Read More
Bayer HealthCare files applications for riociguat in U.S. and Europe
Read More